Date: Friday 26 Nov 2010
Verona Pharma, respiratory diseases treatment developer, is initiating a new higher dose trial of its lead drug, RPL554, in patients with asthma, after receiving the go-ahead from the Dutch authorities.
| London close: Best ever quarterly gain for Footsie | 30-Sep-2009 | ShareCast |
| Small caps round-up: Gulf Keystone, Faroe Petrol... | 30-Sep-2009 | ShareCast |
| Second Price Monitoring Extn | 17-May-2012 | 16:40 | RNS |
| Price Monitoring Extension | 17-May-2012 | 16:35 | RNS |
| Schedule 1 - Sterling Green Group Plc | 14-May-2012 | 07:30 | RNS |
| Restoration - Sterling Green Group plc | 14-May-2012 | 07:30 | RNS |
| Preliminary Results | 14-May-2012 | 07:10 | RNS |
No recent information was found.
No recent information was found.
No recent information was found.
| Yesterday's trading: Carpet King could disappoint | 07-Aug-2007 | This Is Money |
| Currency | UK Pounds |
| Share Price | 0.43p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 0.63 |
| 52 Week Low | 0.23 |
| Volume | 1,020,000 |
| Shares Issued | 303.68m |
| Market Cap | £1.29m |
| Beta | 0.55 |
| RiskGrade | 604 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 10:13 | 20,000 @ 0.41p |
| 08:01 | 1,000,000 @ 0.40p |
| Chair | John Michael Edelson |
| CEO | Syed Tariq Ali |
| Finance Director | Ian Aspinall |
You are here: research